| Disease | dystonia |
| Phenotype | C0034345|pyruvate dehydrogenase deficiency |
| Sentences | 1 |
| PubMedID- 20691944 | Zonisamide was chosen for treatment of secondary paroxysmal dystonia in a patient with pyruvate dehydrogenase deficiency (case 1) and in two patients with neonatal hemochromatosis and family history of neonatal hemochromatosis (cases 2 and 3). |
Page: 1